- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-739X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Minimising treatment-associated risks in systemic cancer therapy ; volume:30 ; number:2 ; day:29 ; month:9 ; year:2007 ; pages:161-168 ; date:4.2008
Pharmacy world & science ; 30, Heft 2 (29.9.2007), 161-168, 4.2008
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11096-007-9157-4
- URN
-
urn:nbn:de:101:1-2021081019290982303546
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jaehde, Ulrich
- Liekweg, Andrea
- Simons, Sven
- Westfeld, Martina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oral Enzyme Therapy in Systemic Analgetic Treatment
Insurance and expanding systemic risks
Systemic risks in securities markets
Systemic Risks from Different Perspectives
Artificial intelligence, systemic risks, and sustainability
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma
AI ethics and systemic risks in finance
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
Adult systemic cat scratch disease associated with therapy for hepatitis C
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis
Estrogen therapy : the benefits and risks
Oral Enzyme Therapy in Systemic Analgetic Treatment
Insurance and expanding systemic risks
Systemic risks in securities markets
Systemic Risks from Different Perspectives
Artificial intelligence, systemic risks, and sustainability
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma
AI ethics and systemic risks in finance
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
Adult systemic cat scratch disease associated with therapy for hepatitis C
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis
Estrogen therapy : the benefits and risks
Oral Enzyme Therapy in Systemic Analgetic Treatment
Insurance and expanding systemic risks
Systemic risks in securities markets
Systemic Risks from Different Perspectives
Artificial intelligence, systemic risks, and sustainability
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma
AI ethics and systemic risks in finance
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
Adult systemic cat scratch disease associated with therapy for hepatitis C
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis